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Purpose: Systemic disease can manifest oral signs at an early phase, which may be crucial 
for the diagnosis and timing of treatment. This report describes two patients who present-
ed with gingival enlargement as an early sign of acute leukemia.
Methods: Two patients presented with oral symptoms including severe gingival enlargement. 
The progress of their symptoms was associated with underlying systemic disease. 
Results: The patients were transferred to the Department of Hematology and diagnosed 
with acute myelomonocytic leukemia. They received appropriate treatment and survived.
Conclusions: Gingival enlargement can be caused by underlying systemic diseases. Accu-
rate diagnosis and timely referral are important for preventing a fatal situation. It must be 
emphasized that some oral signs and symptoms may be closely correlated with systemic 
diseases.
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Leukemia is a type of cancer that affects the bone marrow and peripheral blood, and is 
caused by a malignant proliferation of white blood cell (WBC) precursors. In the leukemic 
state, WBC-forming cells, including myeloid and/or lymphoid cells, exhibit hyperplastic 
changes and produce immature or abnormal WBCs, which leads to the deterioration of 
normal hematopoietic function. Leukemia is clinically divided into acute and chronic forms, 
and acute leukemia can be fatal within a few days if not appropriately treated [1]. Leuke-
mia is further divided into lymphocytic and myelocytic forms based on histogenecity. Acute 
lymphoid leukemia (ALL) is more common in children, representing 50% of all neoplasms 
and 80% of all leukemias in childhood [2]. The prognosis of ALL is poor when it occurs in 
patients older than 30 years [2]. Unlike that of ALL, the incidence of acute myeloid leuke-
mia (AML) increases with age, particularly among people older than 65 years of age, and 
the incidence of AML has increased significantly over the past decade [3]. The incidence of 
leukemia in South Korea in 2011 was 5.7 per 100,000 persons [4]. 
AML has been divided into subtypes M0–M7 according to the French-American-British 
(FAB) classification proposed in 1976, which is based on cytomorphology and cytochemistry 
[5]. However, the FAB classification is limited by the morphologic and genetic findings some-
times being incompatible, and the prognosis being more dependent on genetic findings than 
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on morphologic characteristics [6]. To overcome these shortcom-
ings, a World Health Organization classification was proposed that 
focuses on the genetic properties of the various leukemia subtypes: 
AML with recurrent cytogenetic translocations, AML with myelodys-
plasia-related features, therapy-related AML and myelodysplastic 
syndromes, and AML not otherwise specified [7].
The symptoms of leukemia are associated with the effects of neo-
plastic proliferation and its influence on nonneoplastic hematopoi-
etic cells. By reducing the production of normal erythroblasts, ane-
mia, weakness, constant fatigue, and pallor may occur. Reduction of 
granulocyte production may cause fever and infection. A decreased 
platelet level may result in spontaneous bleeding, petechiae, ecchy-
moses, and bruising. In addition, leukemic cells can directly infiltrate 
the spleen, lymph nodes, central nervous system, and gingiva.
Acute leukemia is often accompanied by oral symptoms, which 
are reported to be early manifestations of acute leukemia in some 
patients [8-11]. Oral complications such as gingival enlargement 
are more frequent in AML than in other types of leukemia, and it is 
reported that gingival enlargement occurs more frequently in the 
M4 and M5 subtypes [11-14]. Temporomandibular joint arthritis is 
usually found in AML [15], and osteolytic lesions in the mandible 
have been reported [16]. It may be rare to encounter leukemic pa-
tients who have oral symptoms as an early indicator of leukemia in 
a routine dental practice. Therefore, dentists may miss the correct 
timing for referral to a hematologist, which can be fatal. Stafford 
et al. [17]. reported that dentists are responsible for early diagnosis 
in a large portion of acute nonlymphocytic leukemias.
This report describes two patients who presented with gingival 
enlargement as an early sign of acute leukemia. We also provide a 
brief review of previous reports in order to highlight the required 




A 59-year-old female patient was referred from a local dental 
clinic with a chief complaint of excessive gingival enlargement that 
had abruptly appeared 20 days previously. The patient had hyper-
tension but was not on any medications associated with gingival 
enlargement. The patient also reported experiencing a severe cold 
30 days previously.
An examination revealed that the patient had generalized gingi-
val enlargement that was more prominent in the maxilla and ante-
A B C
Figure 1. Clinical photographs of case 1 at the initial visit (A–C: facial view).
A B
Figure 2. Clinical photographs of case 1 at the initial visit (A: occlusal view of the maxilla; B: occlusal view of the mandible).
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rior regions. In the maxillary anterior area, there was a discrete, bul-
bous enlargement in the interproximal region. In the maxillary pos-
terior area, there was diffuse enlargement, which extended to the 
alveolar mucosa (Fig. 1A). Gingival enlargement was most severe in 
the palatal area, extending beyond the cingulum of the maxillary 
anterior teeth (Fig. 2). The gingiva was pale blue and had a glazed 
texture with loss of stippling. The gingival consistency was generally 
friable. There was spontaneous bleeding in the canine and premolar 
regions of the palate.
A radiographic examination revealed generalized horizontal bone 
loss that was most prominent in the anterior maxillary region (Fig. 
3). However, the clinical findings were more striking than the radio-
graphic situation. Extraorally, the patient had a bruise adjacent to 
the right lower lip; the patient did not recall any specific traumatic 
injury. There was also mild enlargement and tenderness of the right 
cervical lymph nodes. Most importantly, the patient reported ongo-
ing general weakness and headache. The patient’s oral symptoms 
were suspected to be a manifestation of underlying systemic dis-
ease, and a complete blood count (CBC) with differential analysis 
was performed. The test results revealed a markedly elevated WBC 
count (71.52×103/μL), and decreased red blood cell (2.14×106/μL) 
and platelet (83×103/μL) counts. Immature blood cells, which are 
normally seen only in the bone marrow, were detected in the pe-
ripheral blood. On the basis of the clinical and laboratory findings, 
the patient was suspected to have acute leukemia and was referred 
to the Department of Hematology.
The patient was hospitalized, and further examinations were per-
formed for a definitive diagnosis. A peripheral blood smear revealed 
normocytic normochromic anemia and a markedly increased WBC 
count (blast cells, 72%; segmental neutrophils, 18%; lymphocytes, 7%; 
and monocytes, 1%). Bone marrow aspiration and biopsy revealed hy-
percellularity (50%–60%) and an increased number of blasts, most of 
which were monoblasts and promonocytes. On the basis of these lab-
oratory findings, this patient was diagnosed with acute myelomono-
cytic leukemia (FAB classification: AML M4).
When the definitive diagnosis had been made, dental treatment 
was limited to patient education regarding oral hygiene care and 
mouth gargling with chlorhexidine (Hexamedine, Bukwang Pharm., 
Seoul, Korea). Gingival enlargement was mostly resolved after the 
first phase of chemotherapy without any periodontal interventions. 
Gingival recession and dental calculus were noted in general (Fig. 4). 
The cervical and proximal areas of the patient’s teeth were stained 
due to the prolonged use of chlorhexidine (Fig. 5). During the che-
motherapeutic period, the patient used chlorhexidine and a soft 
brush continuously to prevent oral infection and inflammation. Af-
ter a few cycles of chemotherapy, the patient recovered completely. 
Presently, the patient visits the Department of Hematology as an 
outpatient. No sign of recurrence has been found thus far. 
Case 2
A 49-year-old female was referred for submandibular swelling, 
which occurred after the extraction of mandibular upper second 
and third molars, and generalized gingival swelling. The patient had 
no specific medical history. The dentist at a local clinic had extracted 
the teeth 2 weeks previously, and the patient developed subman-
dibular space swelling 1 week later. The patient seemed to be indif-
ferent to her dental status and poor oral hygiene. An intraoral ex-
amination revealed a probing pocket depth of more than 6–9 mm 
at all sites, easy bleeding on probing, and the presence of heavy 
subgingival calculus (detected on air blowing). The patient had no 
experience of scaling. Pus discharge was also observed in some ar-Figure 3. Radiographic view of case 1.
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Figure 4. Clinical photographs of case 1 after chemotherapy (A–C: facial view).
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eas. The gingival enlargement appeared like a periodontal abscess, 
but it was generalized. The enlargement was most severe on the 
lower dentition, particularly the lower left molar region, and was 
overly bulbous in some interproximal areas. The enlargement ap-
peared fibrotic and friable in nature. An extraoral examination re-
vealed swelling at the mandibular inferior border and tenderness 
to palpation. Routine panoramic x-ray and computed tomography 
also revealed severe periodontal destruction, which was considered 
to be consistent with the clinical findings (Fig. 6). The patient did 
not complain of general weakness or fever.
This patient was initially diagnosed with generalized chronic se-
vere periodontitis, multiple periodontal abscesses, and associated 
submandibular-space abscess. The patient was referred to the De-
partment of Oral and Maxillofacial Surgery, and an oral surgeon 
prescribed Flasinyl (metronidazole, CJ Healthcare, Seoul, Korea) and 
Augmentin (amoxicillin and clavulanate potassium, Ilsung, Seoul, 
Korea) to alleviate the space abscess. The gingival enlargement had 
subsided to some extent at her following visit. Accordingly, anoth-
er extraction of hopeless teeth was performed to remove a possible 
infection source. The patient reported abrupt-onset general weak-
ness 1 day after the extraction and visited an emergency room. 
The patient was hospitalized for systemic examinations. A CBC was 
performed, revealing a WBC count of 38.01×103/μL and decreased 
red blood cell (1.46×106/μL) and platelet (20×103/μL) counts. A 
bone marrow biopsy and genetic examination were conducted to 
confirm the type of acute leukemia present, and the patient was 
A B
Figure 5. Clinical photographs of case 1 after chemotherapy (A: occlusal view of the maxilla; B: occlusal view of the mandible).
B
C D E
Figure 6. Radiographic views of case 2 (A: panoramic view; B: computed tomographic view; C–E: three-dimensional reconstructed images).
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finally diagnosed with acute myelomonocytic leukemia (FAB clas-
sification: AML M4). The potential benefit of periodontal treatment 
and extraction to remove the possibility of oral infection during the 
chemotherapeutic period was explained to the patient and her fam-
ily, but the patient refused the treatment. The patient submitted to 
a few cycles of chemotherapy and autologous bone marrow trans-
plantation, and is in full remission. Presently, the patient visits the 
Department of Hematology for regular check-ups, and as yet, there 
has been no sign of recurrence. 
DISCUSSION
Gingival enlargement can have various causes. For example, acute 
or chronic infection may cause enlargement involving mainly the 
marginal and interproximal gingiva. Specific medications such as 
calcium channel blockers, phenytoin, and cyclosporine are associat-
ed with gingival enlargement. More importantly, gingival enlarge-
ment may be an early manifestation of underlying systemic disease, 
such as acute leukemia, as in the cases reported herein.
The two patients discussed in this report exhibited severe gingival 
enlargement as an early sign of systemic disease, and both were di-
agnosed with acute myelomonocytic leukemia and received hema-
tologic treatment. However, the diagnostic pathway should have 
been more sophisticated in the second case. The dentist was con-
fused by the observation of severe bone destruction on radiogra-
phy, local factors, and abscesses. The highly advanced periodontal 
destruction was considered to be correlated with the gingival en-
largement, and therefore, the initial treatment focused on the re-
moval of infection sources. Consequently, the patient’s leukemic 
state was found only after subsequently expressing general weak-
ness. The second case suggests that periodontal inflammation could 
be a factor that aggravates gingival enlargement associated with 
acute leukemia. At the sites of inflammation, leukocytes are nor-
mally trapped and recruited, and this may intensify leukemic infil-
tration in the leukemic state.
Leukemic gingival enlargement may be misdiagnosed because it 
is rarely seen in everyday dental practice; no other outpatients in 
the authors’ department have reported gingival enlargement as an 
early sign of acute leukemia, as with these two patients, in more 
than 10 years. Moreover, most of the published studies on leukemia 
in the dental field have been case reports, which indicates that it is 
not a common situation.
Leukemia can be tentatively diagnosed by an examination of CBC. 
In the first case, the CBC results raised the suspicion of acute leuke-
mia. However, the symptomatic history of a patient can play an im-
portant role in dental practice. About half of the acute leukemia pa-
tients develop symptoms such as fatigue, weakness, and feelings of 
helplessness within 3 months before disease onset [3]. Loss of appe-
tite and decreased weight are also common symptoms. Fever is the 
presenting symptom in 10% of the patients irrespective of infection, 
and spontaneous bleeding and a tendency toward easy bruising are 
present in 5%. The two patients discussed in this report presented 
with systemic changes, which were crucial diagnostic clues.
If acute leukemia is left untreated or misdiagnosed, life-threaten-
ing conditions including gastrointestinal bleeding, pulmonary hem-
orrhage, and severe infection would develop; a majority of untreat-
ed patients might face a fatal situation within one year [18]. It is 
therefore very important to scrutinize the possible underlying cause 
of gingival enlargement in some patients, since early detection al-
lows prompt intervention and increases the probability of survival.
Oral and periodontal symptoms are reportedly manifested in vari-
ous kinds of leukemia and particularly in acute or subacute forms 
[19,20]. Gingival enlargement is also likely to develop in acute leuke-
mia and in the subleukemic phase [21,22]. Moreover, specific types 
of leukemia (i.e., acute myelomonocytic leukemia [FAB classification: 
M4] and acute monocytic leukemia [FAB classification: M5] are re-
portedly susceptible to the gingival infiltration of leukemic cells 
[12,14]). Dreizen et al. [23] reported that among 1,076 adult leuke-
mia patients, gingival hyperplasia was observed in 66.7% of those 
with M5, 18.5% of those with M4, and 3.7% of those with M1 and 
M2 leukemia. It has also been reported that gingival enlargement 
does not generally develop in edentulous patients [20,23], although 
gingival infiltration of leukemic cells was observed on fine-needle 
aspiration cytology in an edentulous patient with acute M4 leuke-
mia [21].
Gingival enlargement in leukemic patients is known to disappear 
without any specific periodontal treatment [22]. However, enlarged 
gingiva facilitates plaque accumulation and food impaction, and 
complicates oral hygiene practice. This may lead to gingival inflam-
mation with secondary gingival swelling. Patients in these cases are 
also concerned about bleeding during routine oral hygiene practice. 
There has been a report of a possible association between patient-
reported gingival bleeding and a reduced platelet count [24]. Al-
though plummeting platelet counts may evoke a tendency toward 
bleeding, Angst et al. [25] recently demonstrated that there was no 
statistically significant correlation between platelet count and the 
gingival index and bleeding on probing, and that the gingival index 
is, rather, related to plaque accumulation. For the patients discussed 
in the present report, the use of a soft brush with gentle motion 
and supplemental mouth rinsing were recommended.
Dentists may face a dilemma regarding whether any dental treat-
ment will aggravate the leukemic situation and alter the patient’s 
systemic condition [26]. Some may be concerned that while routine 
dental treatment and even self-performed oral hygiene practice will 
increase the risk of bacteremia, untreated inflammation may con-
tribute to morbidity. The following brief guidelines may be of assis-
tance in this context. First, patients with hematologic malignancies 
including leukemia should be clinically and radiologically examined 
for the presence of oral manifestations of the malignancies, peri-
odontal disease, and osteolytic lesions [27,28]. Second, strict oral 
hygiene instructions and the removal of potential sources of oral 
infection should precede any cancer treatment [29]. Clinicians may 
frequently encounter periodontal diseases of varying degrees, and 
chronic periodontitis can be aggravated without specific clinical 
A diagnostic clue for early detection of acute leukemia 
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signs [26]. Therefore, scaling, subgingival debridement, mouth rins-
ing, extraction of nonsalvageable teeth, and administration of an-
tibiotics should be performed prior to cancer therapy. However, all 
procedures should be supervised by hematologic professionals, and 
blood testing for preoperative evaluation is mandatory [27]. More-
over, patients in a severe or recurrent state should only be admin-
istered palliative or emergency treatment.
Gingival enlargement can be caused by underlying systemic dis-
eases that may sometimes be lethal. The present case report de-
scribes two patients presenting with gingival enlargement as an 
early sign of AML. Dentists may be misguided by the rarity of this 
type of encounter, ignorance, or the presence of a combined infec-
tious state, leading them to make incorrect treatment decisions. It 
must always be considered that oral signs and symptoms can be 
signs of a systemic condition.
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